Irritable Bowel Syndrome Public Education Campaign Under Way

Published Online: Sunday, June 1, 2003

Talk IBS is a nationwide public education initiative designed to educate people about the symptoms and management of Irritable Bowel Syndrome and to facilitate informed communication between those with symptoms of IBS and their physicians to aid the diagnosis process. Talk IBS was sparked by the findings of Irritable Bowel Syndrome in Women: The Unmet Needs, a new report from the Society for Women?s Health Research (SWHR). The report indicates that IBS symptoms significantly impact the physical, social, and emotional well-being of IBS sufferers.

The aim of the Talk IBS campaign is to reduce the time it takes for proper diagnosis by providing tools, such as a self-assessment questionnaire, an informational IBS brochure, and a comprehensive Web site, to equip sufferers with information to enhance a dialogue with their health care professionals. Talk IBS materials, as well as the SWHR publication, are available by visiting  or by calling 86-News-4-IBS.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues